Get started
Johnson & JohnsonJohnson & JohnsonJohnson & Johnson

Johnson & Johnson

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsOptionsBondsETFs
Full chart
Full chart

Key facts today


JNJ reported Phase 2/3 ENERGY: Imaavy tripled durable hemoglobin response vs placebo in wAIHA. FDA granted priority review for wAIHA label expansion. Safety matched prior use.
Analyze the impactAnalyze the impact

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪574.10 B‬ USD
Dividend yield (indicated)
2.25%
Price to earnings Ratio (TTM)
27.40
Basic EPS (TTM)
8.74 USD
Net income (FY)
‪26.80 B‬ USD
Revenue (FY)
‪94.18 B‬ USD
Shares float
‪2.40 B‬
Beta (1Y)
−0.16

Employees


Employees (FY)
‪140.8 K‬
Change (1Y)
‪+1 K‬ +0.72%
Revenue / Employee (1Y)
‪668.88 K‬ USD
Net income / Employee (1Y)
‪190.37 K‬ USD

About Johnson & Johnson


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joaquin Duato
Website
jnj.com
Headquarters
New Brunswick
Founded
1887
IPO date
Sep 25, 1944
Identifiers
3
ISIN US4781601046
CFI code
ESVUFR
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Check out other big names from the same industry as JNJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


5.475% YTM
Maturity date Jan 15, 2048
Coupon 3.50% (Fixed)
5.440% YTM
Maturity date Mar 3, 2047
Coupon 3.75% (Fixed)
5.436% YTM
Maturity date Sep 1, 2060
Coupon 2.45% (Fixed)
5.433% YTM
Maturity date Sep 1, 2050
Coupon 2.25% (Fixed)
5.432% YTM
Maturity date Mar 1, 2046
Coupon 3.70% (Fixed)
5.318% YTM
Maturity date Jun 1, 2054
Coupon 5.25% (Fixed)
5.179% YTM
Maturity date Sep 1, 2040
Coupon 2.10% (Fixed)
5.129% YTM
Maturity date Dec 5, 2043
Coupon 4.50% (Fixed)
5.121% YTM
Maturity date May 15, 2041
Coupon 4.85% (Fixed)
5.028% YTM
Maturity date Sep 1, 2040
Coupon 4.50% (Fixed)
5.000% YTM
Maturity date Jan 15, 2038
Coupon 3.40% (Fixed)

See all JNJ bonds 

ETFs holding the stock


VTI
Vanguard Total Stock Market ETF
Weight 0.80%
Market value ‪17.65 B‬
VOO
Vanguard S&P 500 ETF
Weight 0.89%
Market value ‪14.36 B‬
IVV
iShares Core S&P 500 ETF
Weight 0.92%
Market value ‪7.41 B‬
SPY
SPDR S&P 500 ETF TRUST
Weight 0.92%
Market value ‪7.04 B‬
VTV
Vanguard Value ETF
Weight 2.15%
Market value ‪5.13 B‬
XLV
State Street Health Care Select Sector SPDR ETF
Weight 10.41%
Market value ‪4.05 B‬
VIG
Vanguard Div Appreciation ETF
Weight 2.48%
Market value ‪3.11 B‬
VYM
Vanguard High Dividend Yield ETF
Weight 2.29%
Market value ‪2.18 B‬
VHT
Vanguard Health Care ETF
Weight 8.82%
Market value ‪1.64 B‬
CSPX
iShares Core S&P 500 UCITS ETF
Weight 0.92%
Market value ‪1.36 B‬
GSPX
iShares Core S&P 500 UCITS ETF
Weight 0.92%
Market value ‪1.36 B‬

Explore more ETFs 

Frequently asked questions


The current price of JNJ is 238.33 USD — it has increased by 0.63% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Johnson & Johnson stocks are traded under the ticker JNJ.
JNJ stock has risen by 7.21% compared to the previous week, the month change is a 7.76% rise, over the last year Johnson & Johnson has showed a 52.48% increase.
We've gathered analysts' opinions on Johnson & Johnson future price: according to them, JNJ price has a max estimate of 289.00 USD and a min estimate of 210.00 USD. Watch JNJ chart and read a more detailed Johnson & Johnson stock forecast: see what analysts think of Johnson & Johnson and suggest that you do with its stocks.
JNJ reached its all-time high on Mar 2, 2026 with the price of 251.71 USD, and its all-time low was 0.52 USD and was reached on Mar 14, 1968. View more price dynamics on JNJ chart.
See other stocks reaching their highest and lowest prices.
JNJ stock is 1.45% volatile and has beta coefficient of −0.16. Track Johnson & Johnson stock price on the chart and check out the list of the most volatile stocks — is Johnson & Johnson there?
Today Johnson & Johnson has the market capitalization of ‪574.10 B‬, it has increased by 0.38% over the last week.
Yes, you can track Johnson & Johnson financials in yearly and quarterly reports right on TradingView.
Johnson & Johnson is going to release the next earnings report on Jul 15, 2026. Keep track of upcoming events with our Earnings Calendar.
JNJ earnings for the last quarter are 2.70 USD per share, whereas the estimation was 2.68 USD resulting in a 0.85% surprise. The estimated earnings for the next quarter are 2.85 USD per share. See more details about Johnson & Johnson earnings.
Johnson & Johnson revenue for the last quarter amounts to ‪24.06 B‬ USD, despite the estimated figure of ‪23.61 B‬ USD. In the next quarter, revenue is expected to reach ‪24.96 B‬ USD.
JNJ net income for the last quarter is ‪5.24 B‬ USD, while the quarter before that showed ‪5.12 B‬ USD of net income which accounts for 0.00% change. Track more Johnson & Johnson financial stats to get the full picture.
Yes, JNJ dividends are paid quarterly. The last dividend per share was 1.34 USD. As of today, Dividend Yield (TTM)% is 2.20%. Tracking Johnson & Johnson dividends might help you take more informed decisions.
Johnson & Johnson dividend yield was 2.48% in 2025, and payout ratio reached 46.59%. The year before the numbers were 3.39% and 84.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 12, 2026, the company has ‪140.8 K‬ employees. See our rating of the largest employees — is Johnson & Johnson on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Johnson & Johnson EBITDA is ‪33.64 B‬ USD, and current EBITDA margin is 35.71%. See more stats in Johnson & Johnson financial statements.
Like other stocks, JNJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Johnson & Johnson stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Johnson & Johnson technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Johnson & Johnson stock shows the strong buy signal. See more of Johnson & Johnson technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.